New Publication Further Validates Capitainer Technology for Remote Alzheimer's Disease Biomarker Testing
STOCKHOLM, May 21, 2026 /PRNewswire/ -- A new publication in Nature Communications demonstrates that remotely self-collected capillary blood samples can be used to measure Alzheimer's disease biomarkers associated with cognitive decline and function in older adults. The publication,...
View original →